Non-Nucleoside Inhibitors of the Human Cytomegalovirus

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 177-191

Bentham Science Publishers

Access to resources Recommend Favorite

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 925-935

Bentham Science Publishers

Access to resources Recommend Favorite

Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens

By Taneja Charu   Juday Timothy   Gertzog Larry   Edelsberg John   Correll Todd   Hebden Tony   Oster Gerry  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2111-2118

Informa Healthcare

Access to resources Recommend Favorite

Cytostatic Effect of the Nucleoside Analogue 2-Chloroadenosine on Human Prostate Cancer Cell Line

By  

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration

By  

Current Medicinal Chemistry, Vol. 16, Iss. 10, 2009-04 ,pp. : 1184-1191

Bentham Science Publishers

Access to resources Recommend Favorite